Loading…

Soluble HLA Class I Molecules Exert Differentiated Influence on Renal Graft Condition

The function of soluble HLA (sHLA) antigens in the process of immunoregulation and especially in graft tolerance versus rejection has not yet been established. It has been suggested that donor-derived sHLA may exert an immunotolerant influence on the graft. We sought to determine the role of sHLA cl...

Full description

Saved in:
Bibliographic Details
Published in:Transplantation proceedings 2006, Vol.38 (1), p.90-93
Main Authors: Chudyk, A., Masiuk, M., Myślak, M., Domański, L., Sieńko, J., Sulikowski, T., Machaliński, B., Giedrys-Kalemba, S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-60e5f16333d154f64d4f8eb7e6e0c82f6f1832dcde2cd3f9467d8d24619042473
cites cdi_FETCH-LOGICAL-c408t-60e5f16333d154f64d4f8eb7e6e0c82f6f1832dcde2cd3f9467d8d24619042473
container_end_page 93
container_issue 1
container_start_page 90
container_title Transplantation proceedings
container_volume 38
creator Chudyk, A.
Masiuk, M.
Myślak, M.
Domański, L.
Sieńko, J.
Sulikowski, T.
Machaliński, B.
Giedrys-Kalemba, S.
description The function of soluble HLA (sHLA) antigens in the process of immunoregulation and especially in graft tolerance versus rejection has not yet been established. It has been suggested that donor-derived sHLA may exert an immunotolerant influence on the graft. We sought to determine the role of sHLA class I in kidney graft survival by evaluating the influence of these molecules on allotypic lymphocytotoxic antibodies and the concentration of gamma interferon (INF-γ). Analysis of sHLA was performed indirectly utilizing their ability to inhibit lymphocytotoxic reaction dependent on complement activation. To demonstrate the inhibitory properties of sHLA, we modified the NIH microcytotoxic test. Furthermore, we determined the concentration of INF-γ in all sera samples for comparison with the intensity of the cytotoxic test. The comparison of the intensity of cytotoxic test inhibition with the concentration of INF-γ revealed that high concentrations of this cytokine were associated with stronger inhibition of the cytotoxic test, thus with higher concentrations of sHLA class I molecules in recipient sera. We observed that high concentrations of sHLA class I molecules in recipient sera significantly inhibited cytotoxic reactions, which could contribute to a protective influence of sHLA on renal grafts. On the other hand, the observed increase of INF-γ concentration might be caused by sHLA themselves, which would produce a detrimental influence on a transplanted organ. Therefore we concluded that the role of sHLA class I molecules in renal graft condition remains ambiguous.
doi_str_mv 10.1016/j.transproceed.2005.11.090
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67704037</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041134505014491</els_id><sourcerecordid>67704037</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-60e5f16333d154f64d4f8eb7e6e0c82f6f1832dcde2cd3f9467d8d24619042473</originalsourceid><addsrcrecordid>eNqNkFtrFDEUgIModq3-BQmCvs2Y22RmfSvb2i6sCGqfQzY5gSzZpCYZqf_eDLtUH306HM53bh9C7yjpKaHy46GvWcfykJMBsD0jZOgp7cmaPEMrOo28Y5Lx52hFiKAd5WK4QK9KOZCWM8FfogsqByLkyFbo_nsK8z4Avttd4U3QpeAt_pICmDlAwTePkCu-9s5Bhli9rmDxNrowQzSAU8TfIOqAb7N2FW9StL76FF-jF06HAm_O8RLdf775sbnrdl9vt5urXWcEmWonCQyOSs65pYNwUljhJtiPIIGYiTnp6MSZNRaYsdyt28l2skxIul4-Gfkl-nCa21z8nKFUdfTFQAg6QpqLkuNIBOEL-OkEmpxKyeDUQ_ZHnX8rStQiVR3Uv1LVIlVRqprU1vz2vGXeH1vtqfVssQHvz4AuRgfXBhlf_nKjHARfL9z1iYPm5JeHrIrxi0jrM5iqbPL_c88fAuabcw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67704037</pqid></control><display><type>article</type><title>Soluble HLA Class I Molecules Exert Differentiated Influence on Renal Graft Condition</title><source>Elsevier</source><creator>Chudyk, A. ; Masiuk, M. ; Myślak, M. ; Domański, L. ; Sieńko, J. ; Sulikowski, T. ; Machaliński, B. ; Giedrys-Kalemba, S.</creator><creatorcontrib>Chudyk, A. ; Masiuk, M. ; Myślak, M. ; Domański, L. ; Sieńko, J. ; Sulikowski, T. ; Machaliński, B. ; Giedrys-Kalemba, S.</creatorcontrib><description>The function of soluble HLA (sHLA) antigens in the process of immunoregulation and especially in graft tolerance versus rejection has not yet been established. It has been suggested that donor-derived sHLA may exert an immunotolerant influence on the graft. We sought to determine the role of sHLA class I in kidney graft survival by evaluating the influence of these molecules on allotypic lymphocytotoxic antibodies and the concentration of gamma interferon (INF-γ). Analysis of sHLA was performed indirectly utilizing their ability to inhibit lymphocytotoxic reaction dependent on complement activation. To demonstrate the inhibitory properties of sHLA, we modified the NIH microcytotoxic test. Furthermore, we determined the concentration of INF-γ in all sera samples for comparison with the intensity of the cytotoxic test. The comparison of the intensity of cytotoxic test inhibition with the concentration of INF-γ revealed that high concentrations of this cytokine were associated with stronger inhibition of the cytotoxic test, thus with higher concentrations of sHLA class I molecules in recipient sera. We observed that high concentrations of sHLA class I molecules in recipient sera significantly inhibited cytotoxic reactions, which could contribute to a protective influence of sHLA on renal grafts. On the other hand, the observed increase of INF-γ concentration might be caused by sHLA themselves, which would produce a detrimental influence on a transplanted organ. Therefore we concluded that the role of sHLA class I molecules in renal graft condition remains ambiguous.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2005.11.090</identifier><identifier>PMID: 16504672</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Biomarkers ; Cytotoxicity, Immunologic ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Graft Survival - immunology ; Histocompatibility Antigens Class I - blood ; Humans ; Interferon-gamma - blood ; Kidney Transplantation - immunology ; Kidney Transplantation - pathology ; Male ; Medical sciences ; Middle Aged ; Retrospective Studies ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Tissue, organ and graft immunology</subject><ispartof>Transplantation proceedings, 2006, Vol.38 (1), p.90-93</ispartof><rights>2006 Elsevier Inc.</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-60e5f16333d154f64d4f8eb7e6e0c82f6f1832dcde2cd3f9467d8d24619042473</citedby><cites>FETCH-LOGICAL-c408t-60e5f16333d154f64d4f8eb7e6e0c82f6f1832dcde2cd3f9467d8d24619042473</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,777,781,786,787,4010,4036,4037,23911,23912,25121,27904,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17654392$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16504672$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chudyk, A.</creatorcontrib><creatorcontrib>Masiuk, M.</creatorcontrib><creatorcontrib>Myślak, M.</creatorcontrib><creatorcontrib>Domański, L.</creatorcontrib><creatorcontrib>Sieńko, J.</creatorcontrib><creatorcontrib>Sulikowski, T.</creatorcontrib><creatorcontrib>Machaliński, B.</creatorcontrib><creatorcontrib>Giedrys-Kalemba, S.</creatorcontrib><title>Soluble HLA Class I Molecules Exert Differentiated Influence on Renal Graft Condition</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>The function of soluble HLA (sHLA) antigens in the process of immunoregulation and especially in graft tolerance versus rejection has not yet been established. It has been suggested that donor-derived sHLA may exert an immunotolerant influence on the graft. We sought to determine the role of sHLA class I in kidney graft survival by evaluating the influence of these molecules on allotypic lymphocytotoxic antibodies and the concentration of gamma interferon (INF-γ). Analysis of sHLA was performed indirectly utilizing their ability to inhibit lymphocytotoxic reaction dependent on complement activation. To demonstrate the inhibitory properties of sHLA, we modified the NIH microcytotoxic test. Furthermore, we determined the concentration of INF-γ in all sera samples for comparison with the intensity of the cytotoxic test. The comparison of the intensity of cytotoxic test inhibition with the concentration of INF-γ revealed that high concentrations of this cytokine were associated with stronger inhibition of the cytotoxic test, thus with higher concentrations of sHLA class I molecules in recipient sera. We observed that high concentrations of sHLA class I molecules in recipient sera significantly inhibited cytotoxic reactions, which could contribute to a protective influence of sHLA on renal grafts. On the other hand, the observed increase of INF-γ concentration might be caused by sHLA themselves, which would produce a detrimental influence on a transplanted organ. Therefore we concluded that the role of sHLA class I molecules in renal graft condition remains ambiguous.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Cytotoxicity, Immunologic</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Graft Survival - immunology</subject><subject>Histocompatibility Antigens Class I - blood</subject><subject>Humans</subject><subject>Interferon-gamma - blood</subject><subject>Kidney Transplantation - immunology</subject><subject>Kidney Transplantation - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Tissue, organ and graft immunology</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqNkFtrFDEUgIModq3-BQmCvs2Y22RmfSvb2i6sCGqfQzY5gSzZpCYZqf_eDLtUH306HM53bh9C7yjpKaHy46GvWcfykJMBsD0jZOgp7cmaPEMrOo28Y5Lx52hFiKAd5WK4QK9KOZCWM8FfogsqByLkyFbo_nsK8z4Avttd4U3QpeAt_pICmDlAwTePkCu-9s5Bhli9rmDxNrowQzSAU8TfIOqAb7N2FW9StL76FF-jF06HAm_O8RLdf775sbnrdl9vt5urXWcEmWonCQyOSs65pYNwUljhJtiPIIGYiTnp6MSZNRaYsdyt28l2skxIul4-Gfkl-nCa21z8nKFUdfTFQAg6QpqLkuNIBOEL-OkEmpxKyeDUQ_ZHnX8rStQiVR3Uv1LVIlVRqprU1vz2vGXeH1vtqfVssQHvz4AuRgfXBhlf_nKjHARfL9z1iYPm5JeHrIrxi0jrM5iqbPL_c88fAuabcw</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Chudyk, A.</creator><creator>Masiuk, M.</creator><creator>Myślak, M.</creator><creator>Domański, L.</creator><creator>Sieńko, J.</creator><creator>Sulikowski, T.</creator><creator>Machaliński, B.</creator><creator>Giedrys-Kalemba, S.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2006</creationdate><title>Soluble HLA Class I Molecules Exert Differentiated Influence on Renal Graft Condition</title><author>Chudyk, A. ; Masiuk, M. ; Myślak, M. ; Domański, L. ; Sieńko, J. ; Sulikowski, T. ; Machaliński, B. ; Giedrys-Kalemba, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-60e5f16333d154f64d4f8eb7e6e0c82f6f1832dcde2cd3f9467d8d24619042473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Cytotoxicity, Immunologic</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Graft Survival - immunology</topic><topic>Histocompatibility Antigens Class I - blood</topic><topic>Humans</topic><topic>Interferon-gamma - blood</topic><topic>Kidney Transplantation - immunology</topic><topic>Kidney Transplantation - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Tissue, organ and graft immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chudyk, A.</creatorcontrib><creatorcontrib>Masiuk, M.</creatorcontrib><creatorcontrib>Myślak, M.</creatorcontrib><creatorcontrib>Domański, L.</creatorcontrib><creatorcontrib>Sieńko, J.</creatorcontrib><creatorcontrib>Sulikowski, T.</creatorcontrib><creatorcontrib>Machaliński, B.</creatorcontrib><creatorcontrib>Giedrys-Kalemba, S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chudyk, A.</au><au>Masiuk, M.</au><au>Myślak, M.</au><au>Domański, L.</au><au>Sieńko, J.</au><au>Sulikowski, T.</au><au>Machaliński, B.</au><au>Giedrys-Kalemba, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Soluble HLA Class I Molecules Exert Differentiated Influence on Renal Graft Condition</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2006</date><risdate>2006</risdate><volume>38</volume><issue>1</issue><spage>90</spage><epage>93</epage><pages>90-93</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>The function of soluble HLA (sHLA) antigens in the process of immunoregulation and especially in graft tolerance versus rejection has not yet been established. It has been suggested that donor-derived sHLA may exert an immunotolerant influence on the graft. We sought to determine the role of sHLA class I in kidney graft survival by evaluating the influence of these molecules on allotypic lymphocytotoxic antibodies and the concentration of gamma interferon (INF-γ). Analysis of sHLA was performed indirectly utilizing their ability to inhibit lymphocytotoxic reaction dependent on complement activation. To demonstrate the inhibitory properties of sHLA, we modified the NIH microcytotoxic test. Furthermore, we determined the concentration of INF-γ in all sera samples for comparison with the intensity of the cytotoxic test. The comparison of the intensity of cytotoxic test inhibition with the concentration of INF-γ revealed that high concentrations of this cytokine were associated with stronger inhibition of the cytotoxic test, thus with higher concentrations of sHLA class I molecules in recipient sera. We observed that high concentrations of sHLA class I molecules in recipient sera significantly inhibited cytotoxic reactions, which could contribute to a protective influence of sHLA on renal grafts. On the other hand, the observed increase of INF-γ concentration might be caused by sHLA themselves, which would produce a detrimental influence on a transplanted organ. Therefore we concluded that the role of sHLA class I molecules in renal graft condition remains ambiguous.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>16504672</pmid><doi>10.1016/j.transproceed.2005.11.090</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2006, Vol.38 (1), p.90-93
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_67704037
source Elsevier
subjects Adult
Biological and medical sciences
Biomarkers
Cytotoxicity, Immunologic
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Graft Survival - immunology
Histocompatibility Antigens Class I - blood
Humans
Interferon-gamma - blood
Kidney Transplantation - immunology
Kidney Transplantation - pathology
Male
Medical sciences
Middle Aged
Retrospective Studies
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Tissue, organ and graft immunology
title Soluble HLA Class I Molecules Exert Differentiated Influence on Renal Graft Condition
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T16%3A47%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Soluble%20HLA%20Class%20I%20Molecules%20Exert%20Differentiated%20Influence%20on%20Renal%20Graft%20Condition&rft.jtitle=Transplantation%20proceedings&rft.au=Chudyk,%20A.&rft.date=2006&rft.volume=38&rft.issue=1&rft.spage=90&rft.epage=93&rft.pages=90-93&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2005.11.090&rft_dat=%3Cproquest_cross%3E67704037%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-60e5f16333d154f64d4f8eb7e6e0c82f6f1832dcde2cd3f9467d8d24619042473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67704037&rft_id=info:pmid/16504672&rfr_iscdi=true